Marie-Pierre Charron, MD
Otolaryngology · Bismarck, NDNPI 1376081745
Payments from drug & device makers
What this record shows
Inspire Medical Systems, Inc. accounts for 89.8% of it on its own, with 14 other manufacturers making up the rest. Among otolaryngology clinicians in ND with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 53 payments — averaging $66.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$3K
- Acclarent, Inc$56
- Sanofi$55
- Aerin Medical Inc.$37
- Takeda Pharmaceuticals U.S.A., Inc.$30
- Ambu Inc.$25
- plus $155 from 9 others
What the payments were for
- Travel & lodging$1,69748%
- Food & beverage$1,81052%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 34 | $3,148 |
| Acclarent, Inc | 2 | $56 |
| Sanofi | 3 | $55 |
| Aerin Medical Inc. | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| Ambu Inc. | 1 | $25 |
| Olympus America Inc. | 1 | $21 |
| Stryker | 1 | $20 |
| Integra Lifesciences Corporation | 1 | $20 |
| Intersect ENT, Inc. | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Phadia US Inc. | 1 | $17 |
| USWM, LLC | 1 | $15 |
| Optinose US, Inc. | 1 | $13 |
| AstraZeneca | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,506 in reported general payments places this provider in the 90th percentile of 26 otolaryngology providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 12 | $1,182 |
| Azelastine Hcl | 17 | $323 |
| Ofloxacin | 14 | $311 |
| Fluticasone Propionate | 12 | $164 |
| Celecoxib | 17 | $130 |
| Omeprazole | 11 | $119 |
| Cephalexin | 23 | $87 |
| Oxycodone Hcl | 18 | $40 |
| Ondansetron Hcl | 25 | $24 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Bismarck
- David MartiniBismarck$2K
- Jeffrey NelsonBismarck$907
- Andrew HetlandBismarck$148
- Walter MooreBismarck$125
- Susan MathisonFargo$11K
- Michael ShinnersFargo$8K
- Yusuf AgamawiFargo$3K
- Spencer UetzGrand Forks$3K
- Sina KoochakzadehMinot$3K
- Benjamin CampbellGrand Forks$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.